A gene signature found in antibody-producing cells could accelerate vaccine development.

In this Commentary, we explore how non-invasive biomarkers may be used to diagnose pre-symptomatic NASH in patients without them undergoing invasive biopsies.

Archana Vijayakumar, Senior Research Scientist I of Fibrosis at Gilead, presents on understanding disease progression and therapeutic efficacy in preclinical models for NASH.

Vincent Mikol, Precision Medicine Head at Sanofi, leads a discussion on navigating the current challenges of NASH in clinical development.

Amanda Heslegrave, Senior Research Fellow at the UK Dementia Research Centre, UCL, showcases cutting-edge super sensitive immunoassay research at Biomarkers UK 2021.

Quantitative mass spectrometry offers a clinical tool for the discovery of biomarkers, which can be vital in helping to treat certain cancers. In this Commentary article, we explore the applications of mass spectrometry for the identification of triple negative breast cancer and some of the implications for future research.

Key opinion leaders from GlaxoSmithKline and Weill Cornell Medicine discuss future perspectives on neuro-organoids.

Jordi Clarimon, Lead Specialist in Fluid Biomarkers at Lundbeck, leads a discussion on ‘Fluid Biomarkers for Neurodegenerative Diseases.'

Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our March Discussion Group addressing ‘Translational Biomarkers to Guide Clinical Development of CAR T-Cells’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.

Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our February Discussion Group, focusing on ‘Using Biomarkers For Clinical Development & Regulatory Approval,’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.